PIA
NERV icon

Piedmont Investment Advisors’s Minerva Neurosciences NERV Stock Holding History

Piedmont Investment Advisors’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-66
Closed -$4K – 1826
2018
Q2 		$4K Buy
+66
New +$4.01K ﹤0.01% 2249

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return

Piedmont Investment Advisors's NERV Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Minerva Neurosciences (NERV) in Q3 2018, closing a stake of 66 shares — an estimated $4K sold.

Piedmont Investment Advisors first reported a position in NERV in Q2 2018 and held it in 1 quarter. The position peaked at $4K in Q2 2018. 82 funds tracked by Wall St. Rank hold NERV as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Minerva Neurosciences position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 66 Minerva Neurosciences shares in Q3 2018, an estimated $4K.
  • Piedmont Investment Advisors first reported a position in Minerva Neurosciences in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Minerva Neurosciences position peaked at $4K in Q2 2018.
  • 82 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.